Browsing Universitätsklinikum Ulm by Person "Sullivan, Danielle"
Now showing items 1-1 of 1
-
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
Wissenschaftlicher Artikel(Universität Ulm, 2018)